Pancreatic Cancer Research

ResearcherGarvan Institute of Medical ResearchNo recent work listed

Karin A. Oien

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5237-275X; OpenAlex author ID A5103149782, A5111421910. Sources: OpenAlex.

Their work

Papers
13 (first author 1, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
30
Papers, trials and grants by year

2011: 3 papers · 2012: 2 papers · 2013: 1 paper · 2014: 1 paper · 2015: 2 papers · 2016: 1 paper · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper

Papers 13

  1. Prognostic implications of microRNA-21 overexpression in pancreatic ductal adenocarcinoma: an international multicenter study of 686 patients. Last author PMID 36628279↗
  2. Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer. Co-author DOI 10.1053/j.gastro.2020.09.043↗
  3. Hypermutation In Pancreatic Cancer. Co-author DOI 10.1053/j.gastro.2016.09.060↗
  4. Genomic analyses identify molecular subtypes of pancreatic cancer. Co-author DOI 10.1038/nature16965↗
  5. SIRT3 & SIRT7: Potential Novel Biomarkers for Determining Outcome in Pancreatic Cancer Patients. Co-author DOI 10.1371/journal.pone.0131344↗
  6. Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug effic… Co-author DOI 10.15252/emmm.201404827↗
  7. Targeting mTOR dependency in pancreatic cancer. Co-author DOI 10.1136/gutjnl-2013-306202↗
  8. Activation of the IL-6R/Jak/stat pathway is associated with a poor outcome in resected pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s11605-013-2168-7↗
  9. MicroRNA molecular profiles associated with diagnosis, clinicopathologic criteria, and overall survival in patients with resectable pancreatic ductal adenocarc… Last author DOI 10.1158/1078-0432.ccr-11-0679↗
  10. The relationship between tumor inflammatory cell infiltrate and outcome in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1245/s10434-012-2370-y↗
  11. Peripancreatic fat invasion is an independent predictor of poor outcome following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s11605-010-1395-4↗
  12. Clinical potential of microRNAs in pancreatic ductal adenocarcinoma. First author DOI 10.1097/mpa.0b013e3182218ffb↗
  13. Tissue biomarkers for prognosis in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis. Last author DOI 10.1158/1078-0432.ccr-10-3284↗

Closest collaborators

The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Nigel Balfour Jamieson · 10 shared papers, 2011–2022 · strength 0.45
  2. Colin J. McKay · 10 shared papers, 2011–2022 · strength 0.45
  3. Jennifer P. Morton · 5 shared papers, 2012–2022 · strength 0.26
  4. C. Ross Carter · 7 shared papers, 2011–2015 · strength 0.25
  5. Thomas R. Jeffry Evans · 4 shared papers, 2012–2022 · strength 0.22
  6. Owen James Sansom · 4 shared papers, 2012–2022 · strength 0.22
  7. David Kuang-Fu Chang · 3 shared papers, 2014–2022 · strength 0.19
  8. Andrew Victor Biankin · 3 shared papers, 2014–2022 · strength 0.19
  9. Asif Ali · 2 shared papers, 2012–2022 · strength 0.16
  10. Jaswinder Singh Samra · 1 shared paper, 2022 · strength 0.13
  11. Niccola Funel · 1 shared paper, 2022 · strength 0.13
  12. Anthony James Gill · 1 shared paper, 2022 · strength 0.13
  13. Elisa Giovannetti · 1 shared paper, 2022 · strength 0.13
  14. Adam Enver Frampton · 1 shared paper, 2022 · strength 0.13
  15. Colin William Steele · 2 shared papers, 2011–2015 · strength 0.07
  16. Kurt I. Anderson · 2 shared papers, 2014–2015 · strength 0.07
  17. Douglas C. Morran · 2 shared papers, 2012–2014 · strength 0.06
  18. Clement W. Imrie · 2 shared papers, 2011–2012 · strength 0.06
  19. Liane M. McGlynn · 1 shared paper, 2015 · strength 0.05
  20. Simon J. McCluney · 1 shared paper, 2015 · strength 0.05
  21. Paul G. Shiels · 1 shared paper, 2015 · strength 0.05
  22. Simon M. Denley · 1 shared paper, 2013 · strength 0.04
  23. Janine Terra Erler · 1 shared paper, 2015 · strength 0.04
  24. Caroline J. Springer · 1 shared paper, 2015 · strength 0.04
  25. Peter J. Bailey · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.